The new technical services laboratory and conference facility in Noida, India will support continuing industry growth as well as provide local assistance to customers in the region.
Colorcon announced on June 2, 2017 that it has opened a new technical services laboratory and conference facility in Noida, India. The new laboratory, which is Colorcon’s 20th across the world, will support continuing industry growth as well as provide local assistance to customers in the region.
“The northern part of India is significant for Colorcon as it’s a pharmaceutical development and manufacturing hub,” Rajesh Parab, general manager of Colorcon South Asia, said in a press release. “This strategic investment demonstrates Colorcon’s commitment and focus to the fast-growing Indian pharmaceutical market in this region.”
According to Sailesh Verma, regional sales manager, the new laboratory will help customers respond to market dynamics and bring their products to market faster. Verma added that “this facility extends Colorcon’s direct support to customers and supplements the existing laboratory facilities established in Goa to provide a faster turnaround time for their projects and easy access to technical services.”
Customers will have the opportunity to conduct laboratory-scale coating trials at the new facility, using conventional and automated coating equipment that aligns with the equipment in their facilities; this approach could help save development and scale-up time.
The facility also provides the opportunity to extend the educational events offered through the Colorcon Academy, with resources to conduct Colorcon Coating Schools and Formulation Training Programs that will facilitate knowledge sharing and benefit individuals as well as their companies.
Source: Colorcon
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.